| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: | 5213 | 3178 | 2332 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 12301 | 9342 | 1576 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3486 | 2601 | 833 |
 | Paris Biotech Santé [Automatic translation follows] Incubator, nursery and hotel for innovative startups in human health implemented on the Cochin campus. Paris Biotech Santé, an incubator created in 2000 by the University of PARIS CITE, ESSEC, CENTRAL SUPELEC and INSERM, selects and supports ten new innovative projects and companies per year, in the exclusive field of human health: drugs 💊 , medical devices 🏥 , e-health 💻 , AI 🧠. In 2022, the incubator is supported by the Ministry of Higher Education, Research and Innovation, the City of Paris and the Ile de France Region 🇫🇷 . Strengthening teams, helping to develop development … Sectors: | 149 | 51 | 105 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 629 | 381 | 382 |
 | ESPCI Paris - PSL [Automatic translation follows] Engineering school, research and innovation center - #HRS4R label - Component of PSL University ESPCI Paris – PSL (École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris) is a general engineering school that has been training disruptive, adaptable and creative engineers since 1882, with a solid theoretical and experimental background, aware of the challenges facing society. It is part of an internationally recognized research center in physics, chemistry and biology (500 publications per year). It is known for its ability to transform knowledge from fundamental research into breakthrough innovations (2 patents per month, … Sectors: | 167 | 102 | 73 |
National and local authorities